Rosen Law Firm Encourages PomDoctor Investors to Secure Counsel Before Deadline

Investors who purchased PomDoctor securities between October 2025 and December 2025 may be eligible for compensation.

Mar. 15, 2026 at 5:49pm

Got story updates? Submit your updates here. ›

Rosen Law Firm, a global investor rights law firm, is reminding purchasers of PomDoctor Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025 of the important April 7, 2026 lead plaintiff deadline in a securities class action lawsuit. Investors who purchased PomDoctor securities during this period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

Why it matters

The lawsuit alleges that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as insider and affiliate dumping of shares during a price inflation campaign. The company's public statements and risk disclosures allegedly omitted any mention of these false rumors and artificial trading activity driving the stock price.

The details

The class action lawsuit claims that throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) PomDoctor was the subject of a fraudulent stock promotion scheme; (2) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) PomDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

  • The Class Period is from October 9, 2025 to December 11, 2025, inclusive.
  • The lead plaintiff deadline is April 7, 2026.

The players

Rosen Law Firm

A global investor rights law firm that is representing investors in the PomDoctor securities class action lawsuit.

PomDoctor Ltd.

A company whose securities were allegedly the subject of a fraudulent stock promotion scheme.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel.”

— Phillip Kim, Esq. (Rosen Law Firm)

What’s next

To join the PomDoctor class action, investors can go to the Rosen Law Firm's website or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. The deadline to move the Court to serve as lead plaintiff is April 7, 2026.

The takeaway

This case highlights the importance for investors to be cautious of potential stock promotion schemes and artificial trading activity that can inflate stock prices, and the need to carefully review a company's public statements and disclosures. Investors who purchased PomDoctor securities during the Class Period should consider consulting with qualified legal counsel to understand their options for seeking compensation.